• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有证据表明杏仁核参与了5-羟色胺3受体拮抗剂对大鼠饮酒的抑制作用。

Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats.

作者信息

Dyr W, Kostowski W

机构信息

Department of Pharmacology and Physiology of the Nervous System, Institute of Psychiatry and Neurology, Warszawa, Sobieskiego, Poland.

出版信息

Alcohol. 1995 Jul-Aug;12(4):387-91. doi: 10.1016/0741-8329(95)00023-k.

DOI:10.1016/0741-8329(95)00023-k
PMID:7546338
Abstract

Two 5-HT3 receptor antagonists, tropisetron (1 and 10 ng) and ondansetron (10 and 100 ng) were tested for effects on ethanol drinking in Wistar male rats after bilateral microinjection into the amygdala. The animals had limited access (2 h/day) to the 10% (v/v) ethanol solution, food and water were available ad lib during the scheduled access period. Both drugs caused a decrease in ethanol drinking. Tropisetron (1 and 10 ng) decreased ethanol intake during the first hour of access. The lower dose (10 ng) of ondansetron was more effective than the higher (100 ng) dose. The finding implicates amygdaloid 5-HT3 receptors in the mechanism of ethanol intake in Wistar rats.

摘要

将两种5-羟色胺3(5-HT3)受体拮抗剂托烷司琼(1纳克和10纳克)和昂丹司琼(10纳克和100纳克)双侧微量注射到Wistar雄性大鼠杏仁核后,检测它们对大鼠乙醇摄取量的影响。动物对10%(v/v)乙醇溶液的摄取时间有限(每天2小时),在规定的摄取期间可自由获取食物和水。两种药物均使乙醇摄取量减少。托烷司琼(1纳克和10纳克)在摄取的第一小时使乙醇摄入量减少。较低剂量(10纳克)的昂丹司琼比较高剂量(100纳克)更有效。这一发现表明杏仁核5-HT3受体参与了Wistar大鼠乙醇摄取的机制。

相似文献

1
Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats.有证据表明杏仁核参与了5-羟色胺3受体拮抗剂对大鼠饮酒的抑制作用。
Alcohol. 1995 Jul-Aug;12(4):387-91. doi: 10.1016/0741-8329(95)00023-k.
2
The effect of tropisetron injected into the nucleus accumbens septi on ethanol consumption in rats.向大鼠伏隔核注射托烷司琼对其乙醇消耗的影响。
Alcohol. 1995 May-Jun;12(3):195-8. doi: 10.1016/0741-8329(94)00082-o.
3
Serotonin3 receptor antagonism of alcohol intake: effects of drinking conditions.血清素3受体对酒精摄入的拮抗作用:饮酒条件的影响
Alcohol. 1998 May;15(4):291-8. doi: 10.1016/s0741-8329(97)00132-8.
4
Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.海马体和伏隔核的5-羟色胺能神经支配以及5-羟色胺3受体拮抗剂的抗焦虑样作用。
Neuropharmacology. 1993 Oct;32(10):987-93. doi: 10.1016/0028-3908(93)90063-9.
5
Morphine induced changes in ethanol-and water-intake are attenuated by the 5-HT3/4 antagonist tropisetron (ICS 205-930).5-羟色胺3/4拮抗剂托烷司琼(ICS 205-930)可减弱吗啡引起的乙醇和水摄入量的变化。
Psychopharmacology (Berl). 1995 May;119(2):186-92. doi: 10.1007/BF02246160.
6
Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.有证据表明杏仁核参与了5-HT3受体拮抗剂的去抑制作用。
Psychopharmacology (Berl). 1991;104(4):545-51. doi: 10.1007/BF02245664.
7
Effects of 5-HT3 receptor antagonists on ethanol-induced hyperlocomotion in mice.
Pol J Pharmacol. 1995 Jul-Aug;47(4):293-7.
8
5-HT3 antagonists reduce morphine self-administration in rats.5-羟色胺3拮抗剂可减少大鼠的吗啡自我给药行为。
Br J Pharmacol. 1993 Dec;110(4):1341-6. doi: 10.1111/j.1476-5381.1993.tb13966.x.
9
5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake.5-羟色胺3拮抗剂ICS 205-930增强纳曲酮对乙醇摄入量的影响。
Eur J Pharmacol. 2004 May 3;491(2-3):149-56. doi: 10.1016/j.ejphar.2004.03.011.
10
Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats.5-羟色胺(3)受体拮抗剂对嗜酒(P)大鼠在获取、维持和复发条件下每日酒精摄入量的影响。
Alcohol. 2000 May;21(1):73-85. doi: 10.1016/s0741-8329(00)00083-5.

引用本文的文献

1
The role of brain serotonin signaling in excessive alcohol consumption and withdrawal: A call for more research in females.大脑5-羟色胺信号在过度饮酒及戒酒过程中的作用:呼吁对女性展开更多研究。
Neurobiol Stress. 2024 Feb 20;30:100618. doi: 10.1016/j.ynstr.2024.100618. eCollection 2024 May.
2
Evidence for an alcohol-related "harm paradox" in individuals with internalizing disorders: Test and replication in two independent community samples.有内化障碍个体中与酒精相关的“危害悖论”的证据:在两个独立的社区样本中的检验和复制。
Alcohol Clin Exp Res (Hoboken). 2023 Apr;47(4):713-723. doi: 10.1111/acer.15036. Epub 2023 Apr 28.
3
The center of the emotional universe: Alcohol, stress, and CRF1 amygdala circuitry.
情绪宇宙的中心:酒精、应激和 CRF1 杏仁核回路。
Alcohol. 2018 Nov;72:61-73. doi: 10.1016/j.alcohol.2018.03.009. Epub 2018 Mar 30.
4
Histone acetylation of the htr3a gene in the prefrontal cortex of Wistar rats regulates ethanol-seeking behavior.Wistar 大鼠前额皮质中 htr3a 基因的组蛋白乙酰化调节乙醇觅药行为。
Neural Regen Res. 2012 May 5;7(13):1021-8. doi: 10.3969/j.issn.1673-5374.2012.13.009.
5
Chronic self-administration of alcohol results in elevated ΔFosB: comparison of hybrid mice with distinct drinking patterns.慢性酒精自我给药会导致 ΔFosB 升高:具有不同饮酒模式的杂交小鼠的比较。
BMC Neurosci. 2012 Oct 29;13:130. doi: 10.1186/1471-2202-13-130.
6
Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.5-HT3 受体拮抗剂的治疗学:当前用途和未来方向。
Pharmacol Ther. 2011 Jun;130(3):338-47. doi: 10.1016/j.pharmthera.2011.02.003. Epub 2011 Feb 26.
7
A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.一项舍曲林治疗酒精依赖的双盲、随机试验:发病年龄和 5-羟色胺转运体启动子区基因多态性的调节作用[已更正]。
J Clin Psychopharmacol. 2011 Feb;31(1):22-30. doi: 10.1097/JCP.0b013e31820465fa.
8
Neurocircuitry of addiction.成瘾的神经回路。
Neuropsychopharmacology. 2010 Jan;35(1):217-38. doi: 10.1038/npp.2009.110.
9
The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.5-羟色胺3受体在药物滥用中的作用以及作为药物治疗靶点的作用。
CNS Neurol Disord Drug Targets. 2008 Nov;7(5):454-67. doi: 10.2174/187152708786927886.
10
Involvement of amygdala dopamine and nucleus accumbens NMDA receptors in ethanol-seeking behavior in mice.杏仁核多巴胺和伏隔核NMDA受体参与小鼠的觅酒行为。
Neuropsychopharmacology. 2009 May;34(6):1443-53. doi: 10.1038/npp.2008.179. Epub 2008 Oct 1.